Ralo Company is conducting a project with an up-front cost at t = 0 of $1,100,000. The project's subsequent cash flows depends on whether a competitor's product is approved by FDA. There is a 60% chance that the competitive product will be rejected, in which case the company's expected cash flows will be $506,110 at the end of each of the next four years (t = 1 to 4). There is a 40% chance that the competitor's product will be approved, in which case the expected cash flows will be only $151,925 in t = 1 to 4. The company will know for sure one year from today whether the competitor's product has been approved.

If the company waits a year, the project's up-front cost at t = 1 will remain at $1,100,000. The subsequent cash flows will also remain the same with the same probabilities as no waiting, but will be received only for three years (t = 2 to 4). All cash flows are discounted at the company's WACC of 10%.

What will the NPV at t=0 for each of the two strategies be? Round your answer to the nearest dollar, e.g., xxx,xxx. (Hint: Refer to the Evaluation of Investment Timing Option example in Real Options.)

NPV at t=0 if the company proceeds today = $ NPV at t=0 if the company waits a year = $